Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.
作者:
主题词
腺病毒科(Adenoviridae);动物(Animals);癌, 胰腺管(Carcinoma, Pancreatic Ductal);细胞系, 肿瘤(Cell Line, Tumor);综合疗法(Combined Modality Therapy);GPI连接蛋白质类(GPI-Linked Proteins);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);小鼠(Mice);溶瘤病毒疗法(Oncolytic Virotherapy);溶瘤病毒(Oncolytic Viruses);胰腺肿瘤(Pancreatic Neoplasms);T淋巴细胞(T-Lymphocytes);肿瘤微环境(Tumor Microenvironment);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1172/jci.insight.99573
PMID
29618658
发布时间
2023-08-17
- 浏览13

JCI insight
2018年3卷7期
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文